Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As I heard GDBY is currently working on a lot of stuff in relation to the de-listing in Canada. When this is done a lot more UK stuff will come from my perspective.
Just think about:
- up-listing
- PR strategy adjustments
It is always the same. It needs one stone to get everything rolling. The first step is done by deciding to de-list in Canada. The rest will come.
Quite. Lebad is our only positive outlook right now. I struggle myself, fingers crossed for us all.
Good to have you around Lebadinho. I like your positivity. I agree with your sentiment.
he guys, i totally understand displeasure but I have to be honest. I don't see any point here where Geremy or GDBY has completely developed the company away from its actual focus - CBD. Just look at the FSA nonsense. It's not GDBY's fault if it takes the authorities 2 years to find a clear line. And even now, the FSA is not in a position to implement the rules it has defined itself and to remove all products not on the list from the market as soon as possible.
GDBY itself is doing everything to complete the process. As far as I know, the FSA has everything it needs to complete the final authorisation.
During this time, the company has been set up so that they can continue to do business. In the last three months, the focus has clearly been on developing the existing clinic network towards blood testing. The process of connecting pharmacies was optimised.
If you were to look in detail at your investment, you would have noticed that GDBY seems to have implemented pilot projects with many smaller networks (10-25 pharmacies) in the last 3 months with 1-2 sites. A Geremy or Marc do not throw around 450-600 locations by the end of Q3 for nothing because as you all know GDBY is pretty conservative in forecastings.
I know it sounds stupid, but patience is still needed. If by the end of Q3, the pharmacy count does not reach at least 400-450, one should think twice.
And the listing on the LSE or a higher exchange than AQSE in the UK will only be done once the de-listing in Canada is done and GDBY has a GB ISIN. That can't happen before September. It needs approval at the AGM in early August. From then on, maybe another 4-6 weeks until this is fully implemented. As far as I know, the up-listing on the AIM/LSE costs 500k pounds.
So clench your cheeks and think positive.
@Skycity: what do you mean in detail by writing such stupid stuff? Back it up with facts.
Sold the idea as a CBD company, before most people in the UK had not even heard of CBD and now CBD is reported to be used by around 10% of UK adults and worth around £700 million per year and still growing rapidly, he has evolved the company away from its original growing market instead of concentrating on growing that business ....
I have seen no clear direction for the company over the last 3 years, no marketing, no followers on social media ... it is a shame as I have used their CBD products and they are excellent quality and well presented but who is going to buy from a company they don't know exists ... its not even on LSE exchange to allow investors to buy easily.
Gettem I sympathise with your situation as I am in a worse position than you. However I disagree that the CEO is clueless. Geremy has evolved the business to a changing market and adapted accordingly. I am confused by the opening of a clinic in Canada. That was a weird decision and we were sold out with the purchase of Stillcanna but we are not on life support yet like other companies. We are clearly making money. If Goodbody can deliver with 600 clinics we are going to be in a strong position for the future. Unfortunately, this will take time. Time that money cannot afford. We could have invested elsewhere and made a greater return. Geremy is accountable for that. The future of our invested money all depends on the success of blood testing at the moment. The lack of new clinics being registerd in the last 3 weeks suggests that it could go either way. We are all in this for the same reason so lets all hope the big man delivers...
Poor Geremy...he got it so wrong!
200 stores promised vs 3 shops. Lower conversion rate...brilliant
Totally agree, constantly changing the story, the company is clueless!
I don't think I have ever invested in a company where they have changed their story as many times as this mob, one failed idea after another. I bought in 2018 and sold half my position at my breakeven price in Jan 2020, hindsight is a wonderful thing as I should dumped the rest of it as soon as they announced the StillCanna deal.
Many lessons learned from this, main one being dont buy into a company where the CEO has no clue what he is trying to achieve.
He guys I just saw that link on ceo.ca. There will be another market research report from a canadian group available at 27 of June.
https://www.researchfrc.com/goodbody-health-inc-cse-gdby-otcqb-gdbyf-a-solution-for-the-u-k-s-backlogged-public-healthcare-system-initiating-coverage/
@alarno
i totally agree on that!
Different agenda back then, as Skycity knows. It was about cbd. Geremy actually said 200. You are right. Its ok to change direction if something is not working. I do believe big things will be announced but after we have closed down in Canada.
Henry Lee is a former CEO of former Sative Wellness Group?
If opening those stores in relation to current market conditions makes no sense its pretty okay if they didn't have done it, right?
Henry Lees promised 100 walk in Goodbody Wellness stores. Only 3 in the UK if I'm not mistaken. 3% conversion rate, sounds about right for these cowboys....
thats what i'm hoping for. Otherwise it will not be possible from my perspective.
Thanks. 600-650 by Q3 is a very big ask. If there is a big player on board that would make sense.
Currently GDBY has 222 locations in place. After my calculation there are currently 143 locations covered with blood tests (prick AND/OR venous).
From my perspective, the clear focus of the last 2 1/2 month has been shifting the business from covid testing only to blood testing. This takes time. But it was necessary to focus on that to create a solid foundation for regular quarter based revenues. I think they optimized the onboarding process of new locations and trained the staff very well. All fine for me.
I think they will now focus again on adding more locations. I'm also thinking that there will maybe be a bigger cooperation coming up. I heard that Geremy feels still very confident having 600-650 locations by the end of Q3.
I would really be interested in detailed numbers for June. Because thats the first month where more than 125 locations have been able to work at full capacity.
nothing to worry about.
The projected figures given in the Arden report are nowhere near where we are today. LeBadinho is best placed to tell us how many new pharmacies we have had join us in the last 4 weeks. Whatever the number it goes against the comments of Marc Howell. " we are recruiting pharmacies as fast as we can" It is all very slow progress. Some comment on this from Geremy/Marc would help. Clearly cashflow is paramount
What's worrying?
Worrying.....
i totally agree. Great news again by growing their testing offer and strengthen their cooperation with 'Everything Genetic'.
Here the link to the news:
https://www.investegate.co.uk/goodbody-health-inc.--gdby-/rns/genetic-risk-testing-cancer---cardiovascular/202206200700063361P/
And also the link to the Goodbody clinic sub website:
http://health.goodbodyclinic.com/cancer-genetic-tests/
Great news out today re testing for Cancer & Cardiovascular diseases, quite a step forward.
https://ceo.ca/@accesswire/goodbody-health-granted-care-quality-commission-registration
GDBY will now be able to officially provide full privat diagnostics. In addition to that they are no allowed to aplly for a NHS listing.